Low dose oral methotrexate treatment of multiple sclerosis: a pilot study.
AUTOR(ES)
Currier, R D
RESUMO
An 18-month double-blind treatment of multiple sclerosis with low dose oral methotrexate showed it to be well tolerated and suggested effectiveness in exacerbating-remitting MS but not in the exacerbating progressive and chronic progressive stages.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=489824Documentos Relacionados
- Currier RD, Haerer AF, Meydrech, EF. Low dose oral methotrexate treatment of multiple sclerosis: a pilot study
- Methylprednisolone in multiple sclerosis: a comparative dose study.
- Tuberous sclerosis: a genetic study.
- Evoked potentials in the diagnosis of multiple sclerosis: a follow up study.
- Intense immunosuppression in chronic progressive multiple sclerosis: the Kaiser study.
